These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21888902)

  • 1. Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis.
    Yilmaz Y; Eren F; Ayyildiz T; Colak Y; Kurt R; Senates E; Tuncer I; Dolar E; Imeryuz N
    Clin Chim Acta; 2011 Nov; 412(23-24):2296-9. PubMed ID: 21888902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease.
    Hyogo H; Yamagishi S; Maeda S; Kimura Y; Ishitobi T; Chayama K
    Clin Biochem; 2012 Dec; 45(18):1554-7. PubMed ID: 22884488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
    Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Inoue H
    Diabetes Metab Res Rev; 2009 Jan; 25(1):52-6. PubMed ID: 18677713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita Y; Imaizumi T
    Int J Cardiol; 2010 Aug; 143(1):96-8. PubMed ID: 19073347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pigment epithelium-derived factor as an adipokine in psoriasis.
    Nakajima H; Nakajima K; Tarutani M; Sano S
    Arch Dermatol Res; 2012 Jan; 304(1):81-4. PubMed ID: 22120651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity.
    Wiercinska-Drapalo A; Jaroszewicz J; Parfieniuk A; Lapinski TW; Rogalska M; Prokopowicz D
    Regul Pept; 2007 Apr; 140(1-2):1-4. PubMed ID: 17188371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.
    Senates E; Yilmaz Y; Colak Y; Ozturk O; Altunoz ME; Kurt R; Ozkara S; Aksaray S; Tuncer I; Ovunc AO
    Metab Syndr Relat Disord; 2011 Aug; 9(4):287-90. PubMed ID: 21417913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of serum pigment epithelium-derived factor in women with endometriosis.
    Chen L; Fan R; Huang X; Xu H; Zhang X
    Reprod Sci; 2012 Jan; 19(1):64-9. PubMed ID: 22051848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
    Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of weight loss on serum pigment epithelium-derived factor levels.
    Tschoner A; Sturm W; Ress C; Engl J; Kaser S; Laimer M; Laimer E; Klaus A; Tilg H; Patsch JR; Ebenbichler CF
    Eur J Clin Invest; 2011 Sep; 41(9):937-42. PubMed ID: 21314826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with acanthosis nigricans in obese adolescents.
    Galhardo J; Hunt LP; Shield JP
    Diabet Med; 2012 Jul; 29(7):e117-20. PubMed ID: 22288782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease.
    Eren F; Kurt R; Ermis F; Atug O; Imeryuz N; Yilmaz Y
    Clin Biochem; 2012 Jun; 45(9):655-8. PubMed ID: 22465275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy.
    Katakami N; Kaneto H; Yamasaki Y; Matsuhisa M
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e4-7. PubMed ID: 18455830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
    Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
    Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration--a possible link to the development of the disease.
    Machalińska A; Safranow K; Mozolewska-Piotrowska K; Dziedziejko V; Karczewicz D
    Klin Oczna; 2012; 114(2):115-20. PubMed ID: 23346798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.
    Yilmaz Y; Kurt R; Gurdal A; Alahdab YO; Yonal O; Senates E; Polat N; Eren F; Imeryuz N; Oflaz H
    Atherosclerosis; 2011 Jul; 217(1):125-9. PubMed ID: 21513939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.